Melatonin for the Management of Preeclampsia: A Review
Preeclampsia is a disease specific to pregnancy characterised by new-onset hypertension with maternal organ dysfunction and/or fetal growth restriction. It remains a major cause of maternal and perinatal morbidity and mortality. For sixty years, antihypertensives have been the mainstay of treating p...
Main Authors: | Annie Langston-Cox, Sarah A. Marshall, Daisy Lu, Kirsten R. Palmer, Euan M. Wallace |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/3/376 |
Similar Items
-
Measuring of Plasma Melatonin Level in Patients with Preeclampsia
by: Maad M. Shalal, et al.
Published: (2017-10-01) -
EFFECT OF MELATONIN ON THE LEVEL OF CYTOKINES IN PREECLAMPSIA
by: Р. Савка, et al.
Published: (2023-05-01) -
Disruption of the Expression of the Placental Clock and Melatonin Genes in Preeclampsia
by: Aïssatou Bailo Diallo, et al.
Published: (2023-01-01) -
Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
by: Gabriela Ribeiro Valias, et al.
Published: (2022-03-01) -
The reduction of melatonin levels is associated with the development of preeclampsia: a meta-analysis
by: Yuanyan Dou, et al.
Published: (2019-04-01)